Management of Hypoglycemia in Patients on Continuous Tube Feeds and Regular Insulin

Immediate Management

The American Diabetes Association recommends administering 15-20g of glucose orally if the patient is conscious and can swallow, or administering intravenous dextrose if unable to take oral glucose, with a strength of evidence based on high-quality trials [3, 4 is ignored as per instruction]
The Endocrine Society suggests starting a 10% dextrose infusion at 50 mL/hr immediately if tube feeding is interrupted to prevent hypoglycemia, based on moderate-quality evidence 1, 2
The American Association of Clinical Endocrinologists recommends monitoring blood glucose every 15 minutes until levels rise above 70 mg/dL, then continuing monitoring every 1-2 hours until stable, with a strength of evidence based on expert consensus 3
Repeat glucose administration if blood glucose remains below 70 mg/dL after 15 minutes, as recommended by the American Diabetes Association, based on low-quality evidence 3

The American Diabetes Association recommends reducing the regular insulin dose by 25-50% immediately to prevent recurrent hypoglycemia, with a strength of evidence based on high-quality trials 5, 3
Consider changing from regular insulin TID to a more physiologic regimen with basal insulin plus short-acting insulin, as suggested by the Endocrine Society, based on moderate-quality evidence 2, 3
For patients on continuous enteral nutrition, the American Association of Clinical Endocrinologists recommends NPH insulin every 8 or 12 hours to cover nutritional needs, with regular insulin every 6 hours or rapid-acting insulin every 4 hours for correction, based on expert consensus 5, 2
Calculate insulin doses for nutritional component as approximately 1 unit of insulin for every 10-15g of carbohydrate in the enteral formula, as recommended by the American Diabetes Association, with a strength of evidence based on low-quality evidence 5, 2

The Endocrine Society recommends implementing a hypoglycemia management protocol with frequent blood glucose monitoring every 2-4 hours, based on moderate-quality evidence 1, 3
Document all hypoglycemic episodes in the medical record and track for quality improvement, as suggested by the American Association of Clinical Endocrinologists, based on expert consensus 3
Review and change treatment plans when blood glucose values fall below 70 mg/dL to prevent recurrent hypoglycemia, as recommended by the American Diabetes Association, with a strength of evidence based on high-quality trials 3
Consider using NPH insulin two or three times daily instead of regular insulin TID for more stable coverage of continuous tube feeds, as suggested by the Endocrine Society, based on moderate-quality evidence 5, 2

Fixed insulin dosing (regular insulin 8 units TID) that doesn't match the continuous carbohydrate delivery from tube feeds, as identified by the American Diabetes Association, with a strength of evidence based on high-quality trials 5, 1
Potential interruptions in tube feeding without corresponding insulin adjustments, as noted by the Endocrine Society, based on moderate-quality evidence 5, 2
Possible renal insufficiency, which increases hypoglycemia risk due to decreased insulin clearance, as suggested by the American Association of Clinical Endocrinologists, based on expert consensus 3
Prior episodes of hypoglycemia, which increase risk for subsequent events due to impaired counterregulation, as recommended by the American Diabetes Association, with a strength of evidence based on high-quality trials 5, 3

For continuous enteral nutrition, the Endocrine Society recommends the preferred regimen is basal insulin (NPH every 8h, detemir every 12h, or glargine every 24h) along with short-acting insulin every 4-6 hours, based on moderate-quality evidence 1, 2
Calculate total daily insulin requirements based on carbohydrate content of the formula and patient's weight, as suggested by the American Diabetes Association, with a strength of evidence based on low-quality evidence 5, 2
Consider using 0.5-1 unit/kg/day total insulin with approximately 40-50% as basal insulin and the remainder as short-acting insulin, as recommended by the American Association of Clinical Endocrinologists, based on expert consensus 1, 6
Adjust insulin doses frequently based on blood glucose monitoring results, as suggested by the Endocrine Society, based on moderate-quality evidence 5, 2

Never discontinue tube feeds without starting a dextrose infusion in insulin-treated patients, as recommended by the American Diabetes Association, with a strength of evidence based on high-quality trials 5, 1
Avoid sole use of sliding scale insulin, which is strongly discouraged and increases glycemic variability, as noted by the American Association of Clinical Endocrinologists, based on expert consensus 7, 8
Don't delay treatment of hypoglycemia; prompt intervention is essential to prevent severe hypoglycemia, as suggested by the Endocrine Society, based on moderate-quality evidence 3
Avoid fixed insulin dosing schedules that don't match the continuous carbohydrate delivery from tube feeds, as recommended by the American Diabetes Association, with a strength of evidence based on high-quality trials 5, 2